Report - ES/LR/0318/0017Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373:2117 2128. 2. Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten

Please pass captcha verification before submit form